ANI Pharmaceuticals | ANIP - Current Liabilities

Stock Price
77.16
Daily Change
-2.42 -3.04%
Monthly
-1.17%
Yearly
28.62%
Q2 Forecast
80.17

ANI Pharmaceuticals reported $239.51M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 42.1B 1.19B Mar/2026
ANI Pharmaceuticals USD 239.51M 38.6M Mar/2026
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Eli Lilly USD 36.63B 1.41B Mar/2026
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Heron Therapeutics USD 90.52M 5.58M Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Perrigo USD 997.6M 15.3M Mar/2026
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026